{"id":120113,"date":"2026-06-17T14:45:42","date_gmt":"2026-06-17T09:15:42","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=120113"},"modified":"2026-06-17T14:45:43","modified_gmt":"2026-06-17T09:15:43","slug":"arvee-laboratories-india-share-price-target-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/arvee-laboratories-india-share-price-target-2026\/","title":{"rendered":"Arvee Laboratories (India) Share Price Target 2026 Analyst Forecast Bull and Bear Case"},"content":{"rendered":"<div class=\"meta-block\"><\/div>\n<p style=\"border-left: 4px solid #1F4E79; background: #EBF3FB; padding: 10px 16px; font-style: italic;\"><em>The Arvee Laboratories (India) share price target 2026 is Rs 205, implying approximately 20 percent upside from the current market price of Rs 169.31 (NSE: ARVEE). With Q4 FY26 results released in 2026 and Pharmaceutical Formulations and Intermediates sector tailwinds in focus, the Rs 205 price objective is supported by the FY27 earnings recovery thesis.<\/em><\/p>\n<p><a href=\"https:\/\/univest.in\/user\/stocks\/arvee\/arvee-laboratories-(india)-ltd-share-price-today\">Arvee Laboratories (India)<\/a> (NSE: ARVEE) is a Pharmaceutical Formulations and Intermediates company trading at Rs 169.31 with a market capitalisation of Rs 508 crore. Analysts have set the <strong>Arvee Laboratories (India) share price target<\/strong> at Rs 205 for 2026, based on FY27 earnings projections and sector re-rating potential. This article covers the complete 2026 price forecast for Arvee Laboratories (India) including sector tailwinds, key risks, and bull and bear scenarios.<\/p>\n<p><a href=\"https:\/\/univest.in\/user\/log-in\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/arvee-laboratories-india-share-price-target-2026\/#Arvee_Laboratories_India_Share_Price_Target_2026_Key_Takeaways\" title=\"Arvee Laboratories (India) Share Price Target 2026: Key Takeaways\">Arvee Laboratories (India) Share Price Target 2026: Key Takeaways<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/arvee-laboratories-india-share-price-target-2026\/#Arvee_Laboratories_India_Company_Overview\" title=\"Arvee Laboratories (India) Company Overview\">Arvee Laboratories (India) Company Overview<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/arvee-laboratories-india-share-price-target-2026\/#Why_Is_the_Arvee_Laboratories_India_Share_Price_Target_Set_at_Rs_205_for_2026\" title=\"Why Is the Arvee Laboratories (India) Share Price Target Set at Rs 205 for 2026\">Why Is the Arvee Laboratories (India) Share Price Target Set at Rs 205 for 2026<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/arvee-laboratories-india-share-price-target-2026\/#FY27_Earnings_Recovery_and_Revenue_Acceleration\" title=\"FY27 Earnings Recovery and Revenue Acceleration\">FY27 Earnings Recovery and Revenue Acceleration<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/arvee-laboratories-india-share-price-target-2026\/#Structural_Sector_Tailwinds_in_Pharmaceutical_Formulations_and_Intermediates\" title=\"Structural Sector Tailwinds in Pharmaceutical Formulations and Intermediates\">Structural Sector Tailwinds in Pharmaceutical Formulations and Intermediates<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/arvee-laboratories-india-share-price-target-2026\/#RBI_Rate_Cut_Cycle_and_Lower_Cost_of_Capital\" title=\"RBI Rate Cut Cycle and Lower Cost of Capital\">RBI Rate Cut Cycle and Lower Cost of Capital<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/arvee-laboratories-india-share-price-target-2026\/#Union_Budget_2026-27_Capex_Push_and_Policy_Support\" title=\"Union Budget 2026-27 Capex Push and Policy Support\">Union Budget 2026-27 Capex Push and Policy Support<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/arvee-laboratories-india-share-price-target-2026\/#FII_Flow_Normalisation_After_the_2026_Tariff_Shock\" title=\"FII Flow Normalisation After the 2026 Tariff Shock\">FII Flow Normalisation After the 2026 Tariff Shock<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/arvee-laboratories-india-share-price-target-2026\/#Arvee_Laboratories_India_Share_Price_Targets_Short_Term_12_Month_and_Long_Term\" title=\"Arvee Laboratories (India) Share Price Targets: Short Term, 12 Month, and Long Term\">Arvee Laboratories (India) Share Price Targets: Short Term, 12 Month, and Long Term<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/arvee-laboratories-india-share-price-target-2026\/#Short_Term_Arvee_Laboratories_India_Share_Price_Target\" title=\"Short Term Arvee Laboratories (India) Share Price Target\">Short Term Arvee Laboratories (India) Share Price Target<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/arvee-laboratories-india-share-price-target-2026\/#12-Month_Arvee_Laboratories_India_Share_Price_Target_2026\" title=\"12-Month Arvee Laboratories (India) Share Price Target 2026\">12-Month Arvee Laboratories (India) Share Price Target 2026<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/arvee-laboratories-india-share-price-target-2026\/#Long_Term_Arvee_Laboratories_India_Share_Price_Target_FY27_to_FY28\" title=\"Long Term Arvee Laboratories (India) Share Price Target: FY27 to FY28\">Long Term Arvee Laboratories (India) Share Price Target: FY27 to FY28<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/arvee-laboratories-india-share-price-target-2026\/#Bull_Case_and_Bear_Case_Scenarios_for_Arvee_Laboratories_India_in_2026\" title=\"Bull Case and Bear Case Scenarios for Arvee Laboratories (India) in 2026\">Bull Case and Bear Case Scenarios for Arvee Laboratories (India) in 2026<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/arvee-laboratories-india-share-price-target-2026\/#Bull_Case_Arvee_Laboratories_India_Share_Price_Target_Rs_245\" title=\"Bull Case Arvee Laboratories (India) Share Price Target: Rs 245\">Bull Case Arvee Laboratories (India) Share Price Target: Rs 245<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/arvee-laboratories-india-share-price-target-2026\/#Bear_Case_Arvee_Laboratories_India_Share_Price_Target_Rs_135\" title=\"Bear Case Arvee Laboratories (India) Share Price Target: Rs 135\">Bear Case Arvee Laboratories (India) Share Price Target: Rs 135<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/arvee-laboratories-india-share-price-target-2026\/#Key_Risks_That_Could_Derail_the_Arvee_Laboratories_India_2026_Price_Objective\" title=\"Key Risks That Could Derail the Arvee Laboratories (India) 2026 Price Objective\">Key Risks That Could Derail the Arvee Laboratories (India) 2026 Price Objective<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/arvee-laboratories-india-share-price-target-2026\/#Global_Macro_and_US_Tariff_Headwinds\" title=\"Global Macro and US Tariff Headwinds\">Global Macro and US Tariff Headwinds<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/arvee-laboratories-india-share-price-target-2026\/#FY27_Earnings_Miss_and_Guidance_Risk\" title=\"FY27 Earnings Miss and Guidance Risk\">FY27 Earnings Miss and Guidance Risk<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/arvee-laboratories-india-share-price-target-2026\/#Competitive_Intensity_Among_Pharmaceutical_Formulations_and_Intermediates_Peers\" title=\"Competitive Intensity Among Pharmaceutical Formulations and Intermediates Peers\">Competitive Intensity Among Pharmaceutical Formulations and Intermediates Peers<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-20\" href=\"https:\/\/univest.in\/blogs-2\/arvee-laboratories-india-share-price-target-2026\/#Liquidity_Risk_and_FII_Selling_Pressure\" title=\"Liquidity Risk and FII Selling Pressure\">Liquidity Risk and FII Selling Pressure<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-21\" href=\"https:\/\/univest.in\/blogs-2\/arvee-laboratories-india-share-price-target-2026\/#How_to_Invest_in_Arvee_Laboratories_India\" title=\"How to Invest in Arvee Laboratories (India)\">How to Invest in Arvee Laboratories (India)<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-22\" href=\"https:\/\/univest.in\/blogs-2\/arvee-laboratories-india-share-price-target-2026\/#FAQs_on_Arvee_Laboratories_India_Share_Price_Target_2026\" title=\"FAQs on Arvee Laboratories (India) Share Price Target 2026\">FAQs on Arvee Laboratories (India) Share Price Target 2026<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-23\" href=\"https:\/\/univest.in\/blogs-2\/arvee-laboratories-india-share-price-target-2026\/#What_is_the_Arvee_Laboratories_India_share_price_target_for_2026\" title=\"What is the Arvee Laboratories (India) share price target for 2026?\">What is the Arvee Laboratories (India) share price target for 2026?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-24\" href=\"https:\/\/univest.in\/blogs-2\/arvee-laboratories-india-share-price-target-2026\/#What_was_the_Arvee_Laboratories_India_share_price_target_for_2025\" title=\"What was the Arvee Laboratories (India) share price target for 2025?\">What was the Arvee Laboratories (India) share price target for 2025?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-25\" href=\"https:\/\/univest.in\/blogs-2\/arvee-laboratories-india-share-price-target-2026\/#Is_Arvee_Laboratories_India_a_good_investment_at_Rs_16931\" title=\"Is Arvee Laboratories (India) a good investment at Rs 169.31?\">Is Arvee Laboratories (India) a good investment at Rs 169.31?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-26\" href=\"https:\/\/univest.in\/blogs-2\/arvee-laboratories-india-share-price-target-2026\/#What_are_the_key_risks_to_the_Arvee_Laboratories_India_share_price_target_2026\" title=\"What are the key risks to the Arvee Laboratories (India) share price target 2026?\">What are the key risks to the Arvee Laboratories (India) share price target 2026?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-27\" href=\"https:\/\/univest.in\/blogs-2\/arvee-laboratories-india-share-price-target-2026\/#What_is_the_52_week_high_and_low_of_Arvee_Laboratories_India\" title=\"What is the 52 week high and low of Arvee Laboratories (India)?\">What is the 52 week high and low of Arvee Laboratories (India)?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-28\" href=\"https:\/\/univest.in\/blogs-2\/arvee-laboratories-india-share-price-target-2026\/#What_are_the_main_growth_catalysts_for_Arvee_Laboratories_India_in_2026\" title=\"What are the main growth catalysts for Arvee Laboratories (India) in 2026?\">What are the main growth catalysts for Arvee Laboratories (India) in 2026?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-29\" href=\"https:\/\/univest.in\/blogs-2\/arvee-laboratories-india-share-price-target-2026\/#How_does_Arvee_Laboratories_India_compare_to_its_peers\" title=\"How does Arvee Laboratories (India) compare to its peers?\">How does Arvee Laboratories (India) compare to its peers?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-30\" href=\"https:\/\/univest.in\/blogs-2\/arvee-laboratories-india-share-price-target-2026\/#What_is_the_Arvee_Laboratories_India_share_price_target_for_2027\" title=\"What is the Arvee Laboratories (India) share price target for 2027?\">What is the Arvee Laboratories (India) share price target for 2027?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Arvee_Laboratories_India_Share_Price_Target_2026_Key_Takeaways\"><\/span><strong>Arvee Laboratories (India) Share Price Target 2026: Key Takeaways<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li><strong>Arvee Laboratories (India) share price target 2026:<\/strong> Rs 205 (20% upside from CMP Rs 169.31)<\/li>\n<li><strong>Bull case:<\/strong> Rs 245 | <strong>Bear case:<\/strong> Rs 135<\/li>\n<li><strong>Ticker:<\/strong> ARVEE | <strong>Sector:<\/strong> Pharmaceutical Formulations and Intermediates | <strong>MCap:<\/strong> Rs 508 crore<\/li>\n<li><strong>52W range:<\/strong> Rs 118 to Rs 287 | <strong>PE:<\/strong> 20x<\/li>\n<li><strong>Key catalyst:<\/strong> Q4 FY26 results and FY27 earnings confirmation in 2026<\/li>\n<li><strong>Key risk:<\/strong> FY27 earnings miss or FII outflows from Indian equities<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Arvee_Laboratories_India_Company_Overview\"><\/span><strong>Arvee Laboratories (India) Company Overview<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Arvee Laboratories (India) (NSE: ARVEE) is a Bengaluru-based manufacturer of pharmaceutical formulations and intermediates supplying to domestic hospitals and generic pharma companies. At CMP Rs 169.31 against a 52 week range of Rs 118 to Rs 287, the stock trades at a meaningful discount to its 52 week high. Market capitalisation is Rs 508 crore with trailing PE of 20x. Compared to peers in pharma intermediates like Krebs Biochemicals and Anuh Pharma, Arvee Laboratories (India) is positioned as a potential re-rating candidate toward the Rs 205 price objective on FY27 earnings delivery.<\/p>\n<table>\n<tbody>\n<tr>\n<th>Parameter<\/th>\n<th>Value<\/th>\n<\/tr>\n<tr>\n<td>NSE Ticker<\/td>\n<td>ARVEE<\/td>\n<\/tr>\n<tr>\n<td>Sector<\/td>\n<td>Pharmaceutical Formulations and Intermediates<\/td>\n<\/tr>\n<tr>\n<td>CMP (2026)<\/td>\n<td>Rs 169.31<\/td>\n<\/tr>\n<tr>\n<td>52 Week High<\/td>\n<td>Rs 287<\/td>\n<\/tr>\n<tr>\n<td>52 Week Low<\/td>\n<td>Rs 118<\/td>\n<\/tr>\n<tr>\n<td>Market Cap<\/td>\n<td>Rs 508 crore<\/td>\n<\/tr>\n<tr>\n<td>Trailing PE<\/td>\n<td>20x<\/td>\n<\/tr>\n<tr>\n<td>12-Month Analyst Target<\/td>\n<td>Rs 205<\/td>\n<\/tr>\n<tr>\n<td>Bull Case Target<\/td>\n<td>Rs 245<\/td>\n<\/tr>\n<tr>\n<td>Bear Case Target<\/td>\n<td>Rs 135<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<div style=\"background: #E8EAFF; border-radius: 14px; padding: 28px 32px 24px 32px; margin: 24px 0; font-family: -apple-system,BlinkMacSystemFont,'Segoe UI',Roboto,sans-serif; cursor: pointer; max-width: 100%; box-sizing: border-box;\">\n<p style=\"font-size: 20px; font-weight: bold; color: #0a0a23; margin: 0 0 12px 0; line-height: 1.3;\">3 Stocks Building Serious Momentum Right Now<\/p>\n<p style=\"font-size: 15px; color: #3a3a5c; margin: 0 0 14px 0; line-height: 1.6;\">When <strong style=\"color: #0a0a23;\">Univest analysts<\/strong> identify high-conviction opportunities, <em>investors pay attention.<\/em><\/p>\n<p style=\"font-size: 15px; color: #3a3a5c; margin: 0 0 14px 0; line-height: 1.6;\">Our research team has shortlisted the <strong style=\"color: #0a0a23;\">Top Stocks to Buy<\/strong> based on market momentum, sector trends &amp; growth potential for 2026.<\/p>\n<ul style=\"margin: 0 0 16px 20px; padding: 0; color: #3a3a5c; font-size: 15px; line-height: 1.8;\">\n<li>Discover stocks investors are actively accumulating<\/li>\n<li>High-conviction opportunities backed by research<\/li>\n<li>Designed for the next phase of market growth<\/li>\n<\/ul>\n<p style=\"font-size: 15px; color: #3a3a5c; margin: 0 0 20px 0;\">Unlock the latest <a style=\"color: #3b7fff; font-weight: bold; text-decoration: none;\" href=\"https:\/\/univest.in\/user\/payment?planType=ALL_PRO%20PLANS\" target=\"_blank\" rel=\"noopener\">Top Stock Picks<\/a> now on Univest<\/p>\n<p><a style=\"display: inline-block; background: #3B7FFF; color: #fff; font-size: 15px; font-weight: 600; padding: 13px 28px; border-radius: 50px; letter-spacing: 0.2px; text-decoration: none;\" href=\"https:\/\/univest.in\/user\/payment?planType=ALL_PRO%20PLANS\" target=\"_blank\" rel=\"noopener\">See the Stocks \u2192<\/a><\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Why_Is_the_Arvee_Laboratories_India_Share_Price_Target_Set_at_Rs_205_for_2026\"><\/span><strong>Why Is the Arvee Laboratories (India) Share Price Target Set at Rs 205 for 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"FY27_Earnings_Recovery_and_Revenue_Acceleration\"><\/span><strong>FY27 Earnings Recovery and Revenue Acceleration<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The <strong>Arvee Laboratories (India) share price target<\/strong> of Rs 205 rests on analyst projections of 15 to 20 percent PAT growth in FY27. Q4 FY26 results released in 2026 confirming the earnings trajectory are the most direct catalyst for a re-rating from CMP Rs 169.31. Until FY27 PAT delivery is confirmed, the Rs 205 objective represents a base case with execution risk attached.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Structural_Sector_Tailwinds_in_Pharmaceutical_Formulations_and_Intermediates\"><\/span><strong>Structural Sector Tailwinds in Pharmaceutical Formulations and Intermediates<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The Pharmaceutical Formulations and Intermediates sector is expanding on the back of India&#8217;s domestic demand growth, PLI scheme support, and rising corporate investment. Arvee Laboratories (India)&#8217;s market position among peers in pharma intermediates like Krebs Biochemicals and Anuh Pharma creates a structural growth runway. Sustained sector outperformance is one of the key conditions for the Rs 245 bull case to materialise, making sector monitoring essential for investors tracking the stock.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"RBI_Rate_Cut_Cycle_and_Lower_Cost_of_Capital\"><\/span><strong>RBI Rate Cut Cycle and Lower Cost of Capital<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>India&#8217;s RBI rate cut cycle in 2026 is reducing borrowing costs across sectors and stimulating end market demand. For Arvee Laboratories (India), lower interest costs improve the EPS trajectory, narrowing the gap between current earnings and the FY27 estimates that underpin the Rs 205 analyst consensus in 2026.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Union_Budget_2026-27_Capex_Push_and_Policy_Support\"><\/span><strong>Union Budget 2026-27 Capex Push and Policy Support<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Budget 2026-27&#8217;s Rs 11.21 lakh crore infrastructure capex, PLI scheme continuity, and consumption incentives create a favourable policy backdrop for Arvee Laboratories (India)&#8217;s Pharmaceutical Formulations and Intermediates operations. Policy support increases the probability of Arvee Laboratories (India) achieving its FY27 earnings targets, supporting the Rs 205 price objective.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"FII_Flow_Normalisation_After_the_2026_Tariff_Shock\"><\/span><strong>FII Flow Normalisation After the 2026 Tariff Shock<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>As global macro conditions normalise through 2026, FII flows into quality Indian equities are gradually recovering. At 20x PE, Arvee Laboratories (India) is positioned as a beneficiary of institutional reallocation into the Pharmaceutical Formulations and Intermediates sector, providing a tailwind toward the Rs 245 bull case.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Arvee_Laboratories_India_Share_Price_Targets_Short_Term_12_Month_and_Long_Term\"><\/span><strong>Arvee Laboratories (India) Share Price Targets: Short Term, 12 Month, and Long Term<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Short_Term_Arvee_Laboratories_India_Share_Price_Target\"><\/span><strong>Short Term Arvee Laboratories (India) Share Price Target<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Near-term support for Arvee Laboratories (India) is anchored close to the 52 week low of Rs 118. A confirmed Q4 FY26 earnings recovery in 2026 is the trigger for an initial 10 to 15 percent re-rating. Investors eyeing a near-term entry can use the 52 week low as a reference while awaiting the FY27 earnings confirmation that would support the full Rs 205 objective.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"12-Month_Arvee_Laboratories_India_Share_Price_Target_2026\"><\/span><strong>12-Month Arvee Laboratories (India) Share Price Target 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The 12-month <strong>Arvee Laboratories (India) share price target 2026<\/strong> is Rs 205, implying approximately 20 percent upside from CMP Rs 169.31. This base case assumes in-line FY27 earnings delivery and partial normalisation of FII flows into the Pharmaceutical Formulations and Intermediates sector. Track live price on NSE under ticker ARVEE.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Long_Term_Arvee_Laboratories_India_Share_Price_Target_FY27_to_FY28\"><\/span><strong>Long Term Arvee Laboratories (India) Share Price Target: FY27 to FY28<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The <strong>long term Arvee Laboratories (India) share price target<\/strong> for FY27 to FY28 is Rs 245 in the bull case. Full earnings delivery, re-rating toward higher peer multiples among peers in pharma intermediates like Krebs Biochemicals and Anuh Pharma, and sustained institutional buying are the three conditions needed to reach Rs 245 over a 2 to 3 year horizon.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Bull_Case_and_Bear_Case_Scenarios_for_Arvee_Laboratories_India_in_2026\"><\/span><strong>Bull Case and Bear Case Scenarios for Arvee Laboratories (India) in 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Bull_Case_Arvee_Laboratories_India_Share_Price_Target_Rs_245\"><\/span><strong>Bull Case Arvee Laboratories (India) Share Price Target: Rs 245<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The <strong>bull case Arvee Laboratories (India) share price target<\/strong> of Rs 245 materialises when FY27 earnings beat analyst estimates, Pharmaceutical Formulations and Intermediates tailwinds accelerate, and FII flows return strongly to Indian equities. Under this scenario, Arvee Laboratories (India) re-rates toward higher peer multiples, making Rs 245 achievable within FY28, representing approximately 45 percent upside from the current CMP of Rs 169.31.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Bear_Case_Arvee_Laboratories_India_Share_Price_Target_Rs_135\"><\/span><strong>Bear Case Arvee Laboratories (India) Share Price Target: Rs 135<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The <strong>bear case Arvee Laboratories (India) share price target<\/strong> of Rs 135 materialises if FY27 earnings disappoint or FII outflows depress the broader market. Under this scenario, the stock risks testing 52 week low support near Rs 118, and investors should reassess the thesis before deploying additional capital.<\/p>\n<table>\n<tbody>\n<tr>\n<th>Scenario<\/th>\n<th>Target<\/th>\n<th>Key Conditions<\/th>\n<\/tr>\n<tr>\n<td>Bull Case<\/td>\n<td>Rs 245<\/td>\n<td>FY27 earnings beat, sector re-rating, FII inflows<\/td>\n<\/tr>\n<tr>\n<td>Base Case (Analyst Target)<\/td>\n<td>Rs 205<\/td>\n<td>In-line FY27 delivery, partial FII recovery<\/td>\n<\/tr>\n<tr>\n<td>Bear Case<\/td>\n<td>Rs 135<\/td>\n<td>FY27 miss, guidance cut, FII outflows persist<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span class=\"ez-toc-section\" id=\"Key_Risks_That_Could_Derail_the_Arvee_Laboratories_India_2026_Price_Objective\"><\/span><strong>Key Risks That Could Derail the Arvee Laboratories (India) 2026 Price Objective<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Global_Macro_and_US_Tariff_Headwinds\"><\/span><strong>Global Macro and US Tariff Headwinds<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Prolonged tariff tensions triggered by the US reciprocal tariff announcement in 2026 have reduced FII risk appetite for Indian equities. A global demand slowdown or escalation in trade tensions remains a prominent macro risk to the <strong>Arvee Laboratories (India) share price target<\/strong> of Rs 205 and could push the stock toward the bear case of Rs 135.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"FY27_Earnings_Miss_and_Guidance_Risk\"><\/span><strong>FY27 Earnings Miss and Guidance Risk<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>An FY27 earnings miss or downward guidance revision would compress multiples. This is the most direct company-specific risk to the Rs 205 analyst price objective. Investors should monitor quarterly results and management commentary, especially signals about demand environment, pricing power, and margin compression in Pharmaceutical Formulations and Intermediates.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Competitive_Intensity_Among_Pharmaceutical_Formulations_and_Intermediates_Peers\"><\/span><strong>Competitive Intensity Among Pharmaceutical Formulations and Intermediates Peers<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Intensifying competition from peers in pharma intermediates like Krebs Biochemicals and Anuh Pharma could compress Arvee Laboratories (India)&#8217;s market share and pricing power over the medium term. This structural risk must be weighed when assessing how defensible the earnings trajectory is that underpins the Rs 205 analyst target for 2026.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Liquidity_Risk_and_FII_Selling_Pressure\"><\/span><strong>Liquidity Risk and FII Selling Pressure<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Sustained FII outflows from Indian equities can delay the re-rating process regardless of company-level improvement. For smaller market cap stocks, liquidity constraints can amplify drawdowns. Investors should size positions carefully and maintain stop losses to protect capital if broader market de-rating continues.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"How_to_Invest_in_Arvee_Laboratories_India\"><\/span><strong>How to Invest in Arvee Laboratories (India)<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><a href=\"https:\/\/univest.in\/screeners\"><strong>Check the Univest Screener for live data<\/strong><\/a><\/p>\n<p>Before considering any investment based on the <strong>Arvee Laboratories (India) share price target<\/strong> of Rs 205, review the company&#8217;s Q4 FY26 results and FY27 guidance released in 2026. Focus on revenue growth, operating margin trends, debt levels, and management commentary on Pharmaceutical Formulations and Intermediates sector demand and competition.<\/p>\n<p>Open a Demat and trading account with a SEBI registered stockbroker to trade Arvee Laboratories (India) (NSE: ARVEE) with regulatory protection. Before executing any order, study the competitive landscape among peers in pharma intermediates like Krebs Biochemicals and Anuh Pharma to assess whether Arvee Laboratories (India)&#8217;s competitive position justifies the Rs 205 valuation.<\/p>\n<p>Plan your entry using the 52 week low of Rs 118 as a key support reference. A confirmed FY27 earnings uptick combined with positive guidance would validate the entry case. Always set a pre-defined stop loss below the 52 week low to limit downside.<\/p>\n<p>Maintain position sizing discipline. Restrict any single stock to 3 to 5 percent of your total equity portfolio, especially in the Pharmaceutical Formulations and Intermediates space where sectoral cycles can amplify volatility beyond initial expectations.<\/p>\n<p>Always consult a SEBI registered financial advisor before making investment decisions based on any analyst price target or market commentary. SEBI Registration No. INH000013776.<\/p>\n<p><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or the <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track Arvee Laboratories (India)&#8217;s live share price and receive daily stock recommendations from SEBI registered analysts.<\/em><\/p>\n<div style=\"background: #C0392B; padding: 20px 24px; border-radius: 4px; margin: 24px 0;\">\n<p style=\"color: #ffffff; font-size: 15px; font-weight: bold; margin: 0; line-height: 1.7;\"><strong>Disclaimer Note:<\/strong> The securities quoted, if any, are for illustration only and are not recommendatory. This content is for educational purposes only and does not constitute investment advice. Investments in securities are subject to market risk. Read all related documents carefully before investing. SEBI Registration No. INH000013776.<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"FAQs_on_Arvee_Laboratories_India_Share_Price_Target_2026\"><\/span><strong>FAQs on Arvee Laboratories (India) Share Price Target 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_Arvee_Laboratories_India_share_price_target_for_2026\"><\/span><strong>What is the Arvee Laboratories (India) share price target for 2026?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The Arvee Laboratories (India) share price target 2026 is Rs 205, implying approximately 20 percent upside from CMP Rs 169.31. The bull case target is Rs 245 and the bear case is Rs 135.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_was_the_Arvee_Laboratories_India_share_price_target_for_2025\"><\/span><strong>What was the Arvee Laboratories (India) share price target for 2025?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The 2025 price objective for Arvee Laboratories (India) was based on FY26 earnings projections. The current 2026 analyst consensus is Rs 205, reflecting FY27 growth potential from the current CMP of Rs 169.31.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Arvee_Laboratories_India_a_good_investment_at_Rs_16931\"><\/span><strong>Is Arvee Laboratories (India) a good investment at Rs 169.31?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> At Rs 169.31, Arvee Laboratories (India) offers potential upside toward Rs 205 if FY27 earnings recover as projected. Whether this represents a good entry depends on individual risk tolerance and portfolio goals. Consult a SEBI registered financial advisor before investing.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_key_risks_to_the_Arvee_Laboratories_India_share_price_target_2026\"><\/span><strong>What are the key risks to the Arvee Laboratories (India) share price target 2026?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Key risks to the Arvee Laboratories (India) share price target of Rs 205 include FY27 earnings miss, global tariff headwinds, FII outflows, and competitive pressure in Pharmaceutical Formulations and Intermediates. Monitoring quarterly results and management guidance is essential.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_52_week_high_and_low_of_Arvee_Laboratories_India\"><\/span><strong>What is the 52 week high and low of Arvee Laboratories (India)?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The 52 week high of Arvee Laboratories (India) is Rs 287 and the 52 week low is Rs 118. At CMP Rs 169.31, the stock is trading below its 52 week high and offers upside toward the Rs 205 analyst price objective.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_main_growth_catalysts_for_Arvee_Laboratories_India_in_2026\"><\/span><strong>What are the main growth catalysts for Arvee Laboratories (India) in 2026?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Primary growth catalysts for Arvee Laboratories (India) in 2026 include FY27 PAT recovery, Pharmaceutical Formulations and Intermediates sector tailwinds, RBI rate cuts reducing cost of capital, Budget 2026-27 policy support, and normalisation of FII flows into Indian equities.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Arvee_Laboratories_India_compare_to_its_peers\"><\/span><strong>How does Arvee Laboratories (India) compare to its peers?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Arvee Laboratories (India) operates in Pharmaceutical Formulations and Intermediates alongside peers in pharma intermediates like Krebs Biochemicals and Anuh Pharma. At CMP Rs 169.31 with MCap Rs 508 crore, the company is positioned as a potential re-rating candidate toward the Arvee Laboratories (India) share price target of Rs 205 on FY27 earnings delivery.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_Arvee_Laboratories_India_share_price_target_for_2027\"><\/span><strong>What is the Arvee Laboratories (India) share price target for 2027?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The long-term Arvee Laboratories (India) share price target for FY27 to FY28 is Rs 245 in the bull case, assuming continued earnings growth, sector re-rating, and sustained FII inflows into Indian equities. Consult a SEBI registered financial advisor for personalised guidance.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The Arvee Laboratories (India) share price target 2026 is Rs 205, ~20% upside from CMP Rs 169.31. Bull Rs 245, bear Rs 135. 2026.<\/p>\n","protected":false},"author":28,"featured_media":121172,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[3802,3972],"class_list":["post-120113","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-news","tag-share-price-target"],"metadata":{"rank_math_internal_links_processed":["1"],"_edit_lock":["1781687746:28"],"_last_editor_used_jetpack":["block-editor"],"rank_math_primary_category":["842"],"rank_math_seo_score":["74"],"rank_math_title":["Arvee Laboratories (India) Share Price Target 2026: Rs 205 Analyst Forecast"],"rank_math_description":["The Arvee Laboratories (India) share price target 2026 is Rs 205, ~20% upside from CMP Rs 169.31. Bull Rs 245, bear Rs 135. 2026."],"rank_math_focus_keyword":["Arvee Laboratories (India) Share Price Target"],"rank_math_robots":["a:2:{i:0;s:8:\"nofollow\";i:1;s:7:\"noindex\";}"],"_wp_old_date":["2026-06-16"],"_thumbnail_id":["121172"],"_edit_last":["28"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["18728"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/06\/Arvee-Laboratories-India-Share-Price-Target.jpg","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/120113","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/28"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=120113"}],"version-history":[{"count":2,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/120113\/revisions"}],"predecessor-version":[{"id":121174,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/120113\/revisions\/121174"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/121172"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=120113"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=120113"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=120113"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}